BackgroundHemangiopericytoma was first named as a soft tissue tumor in 1942. It is a group of tumors composed of short spindle cells with pericyte growth. It is rare in clinical practice and accounts for 0.4 of all tumors originating in the central nervous system 0.4%, with a high degree of recurrence and the potential for metastasis outside the central nervous system.Case presentationWe report 4 patients, including 1 male and 3 females. All patients had headache, dizziness, and fatigue. The first and fourth patients showed acute exacerbation, paroxysmal limb twitching, flexion of both upper limbs, straightening of both lower limbs, unconsciousness, unresponsiveness, and upper eyeballs. Turning and closing of the teeth, 1 out of 2 patients was accompanied by a tongue bite. All 4 patients underwent imaging examinations. Considering the possibility of meningiomas and gliomas, all 4 patients underwent surgical resection and were followed up many times after the operation. The first case was followed up for 68 months and passed away due to recurrence without treatment. The second case was followed up for 50 months and relapsed at 42 months after the operation. It relapsed again 18 months after the operation and passed away with multiple metastases throughout the body; the third patient died in time The 4 patients were followed up for 32 months and 9 months respectively, and there is no recurrence at present.ConclusionsMeningeal HPC is a rare clinical tumor. 4 cases were followed up for 9-68 months, 2 cases recurred after surgery, and 1 case had multiple metastases throughout the body. It is not easy to distinguish HPC from meningioma on imaging. The diagnosis still depends on pathological examination, combined with the combined diagnosis of STAT6, CD34 and ALDHIA1 immunohistochemical markers, which can effectively improve the diagnosis and differential diagnosis of the disease. Because HPC is prone to recurrence and metastasis, Long-term follow-up and timely follow-up are still needed after operation.